Lisette Molina, MD
Obstetrics & Gynecology · South Miami, FLNPI 1790957876
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $758 of the $889 with a category attached, or 85.3%. 15 manufacturers reported payments, led by AbbVie at 28.0% of the total. Reporting peaked in 2023 at $318 and has fallen 89.6% since, to $33 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in FL, where the typical reported total is $820.
Across 41 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$249
- Astellas Pharma US Inc$159
- Vertical Pharmaceuticals, LLC$137
- Mayne Pharma Commercial LLC$73
- Hologic Sales And Service, LLC$63
- AMAG Pharmaceuticals, Inc.$44
- plus $165 from 9 others
Across 28 payments — averaging $3060.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ventana Medical Systems, Inc.$52K
- Merck$23K
- AbbVie$11K
What the payments were for
- Food & beverage$75885%
- Education$13115%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 13 | $249 |
| Astellas Pharma US Inc | 4 | $159 |
| Vertical Pharmaceuticals, LLC | 8 | $137 |
| Mayne Pharma Commercial LLC | 3 | $73 |
| Hologic Sales And Service, LLC | 2 | $63 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Boston Scientific | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Amgen | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Lupin Inc. | 1 | $17 |
| Minerva Surgical, Inc | 1 | $15 |
| Coopersurgical, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $12 |
How this compares
$889 in reported general payments places this provider in the 50th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $651 |
| ValacyclovirValacyclovir Hcl | 15 | $205 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in South Miami
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.